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ORIGINAL ARTICLE

Female family members lack understanding of indeterminate
negative BRCA1/2 test results shared by probands
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Genetic test results have important implications for close family members.
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Indeterminate negative results are the most common outcome of BRCA1/2 mutation testing. Little is known about family members' understanding of indeterminate
negative BRCA1/2 test results. The purpose of this mixed‐methods study was to investigate how daughters and sisters received and understood genetic test results as
shared by their mothers or sisters. Participants included 81 women aged 40–74 with
mothers or sisters previously diagnosed with breast cancer and who received indeterminate negative BRCA1/2 test results. Participants had never been diagnosed with
breast cancer nor received their own genetic testing or counseling. This Institutional
Review Board‐approved study utilized semi‐structured interviews and surveys.
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test results are not well understood by family members. Lack of understanding may

Participants reported low amounts of information shared with them. Most women
was no genetic component to the pattern of cancer in their families. Only seven of
81 women accurately described test results consistent with the meaning of an indeterminate negative. Our findings demonstrate that indeterminate negative genetic
lead to an inability to effectively communicate results to primary care providers and
missed opportunities for prevention, screening, and further genetic testing. Future
research should evaluate acceptability and feasibility of providing family members
letters they can share with their own primary care providers.
KEYWORDS
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1 | I NTRO D U C TI O N

factors (BreastCancer.org, 2018). Women who have elevated breast
cancer risk require different detection and prevention options than

Breast cancer is the second leading cause of cancer death in women

the general population. Appropriate detection and prevention op-

(American Cancer Society, 2016). While as many as 10% of all breast

tions can be provided through precision medicine where providers

cancers are hereditary, an additional 15%–20% of breast cancers

individualize care based on personalized risk, including genetic, fa-

occur in family clusters due to shared genetics and environmental

milial, behavioral, and environmental risk factors. Specific genetic
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risk may be identified through genetic tests and family history.

communicating indeterminate negative results, which can be diffi-

Genetic counselors are specifically trained to help people under-

cult to understand, remember, and explain. Additionally, summary

stand individual genetic test results and provide counseling accord-

letters may be used to alert counselees that genetic science evolves

ing to those results. A BRCA test is a test for mutations occuring in

over time and can, thus, explain that additional testing may become

the BRCA1 and BRCA2 genes.

available in the future.

Genetic counselors provide results of genetic tests to women

Because indeterminate negative results are so difficult to dis-

with breast cancer who have obtained genetic testing (counselees).

cuss and understand, it is important to investigate information

Counselees then are primarily responsible for sharing test results

transfer within families. Presently, the current state of informa-

and risk information with family members. Informed family members

tion transfer related to uninformative negative BRCA test re-

may follow up with their primary care providers to discuss personal

sults has not been explored from family members' perspectives.

risk potential and receive risk‐stratified care.

Improved understanding may lead to enhanced ways to facilitate

Unfortunately, identified genetic information is not always

communication about genetic test results and risk within families.

shared with family members from counselees or, when shared with

Therefore, the purpose of this mixed‐method descriptive study

family members, is often incomplete or incorrect. Additionally, ge-

was to investigate whether and how daughters and sisters (par-

netic information may be misunderstood by counselees, family

ticipants) received and understood information from the mothers

members, or both (Vos et al., 2011). Indeed, Vos et al. (2011) referred

and sisters (counselees) who received indeterminate genetic test

to family communication following genetic counseling as a “whisper

results following BRCA1/2 testing for breast cancer.

game,” with errors accumulating each time information is shared,

Specifically, this study aimed to answer the following questions:

recalled, or interpreted. Counselees often believe family members

(a) How much information did participants perceive was shared by

understand shared results, when in fact misunderstandings of infor-

counselees? (b) What is participants' understanding of indeterminate

mation are common (Vos et al., 2011).

negative genetic test results? (c) What method(s) of communication

Indeterminate negative results appear to be particularly dif-

was used to share genetic testing information with participants? (d)

ficult to communicate and understand (Cypowyj et al., 2009). An

Did participants report that summary letters were shared with them

indeterminate negative result is the most common outcome of

by counselees?

BRCA1/2 (BRCA1 and BRCA2 genes) mutation testing when testing a proband (i.e., the first person to undergo BRCA1/2 testing
in a family; Nelson et al., 2013). In the absence of a previously

2 | M E TH O DS

identified mutation, an indeterminate negative result means an
unidentified genetic cause may still underlie patterns of cancer in

This paper presents results of a descriptive, mixed‐methods,

the family. The term “indeterminate negative” has been used in-

Institutional Review Board (IRB)‐approved study. Data were col-

terchangeably in the literature with words such as “inconclusive”

lected from October 2013 to February 2014. An analysis of other

and “uninformative” to indicate that no specific genetic mutation

study aims have been published elsewhere (Himes, Clayton, et al.,

was found. It is important to note that a test result of “no mu-

2016).

tation identified” is not synonymous with “no mutation exists.”
When no mutations have been identified, future risk assessments
must be based on family and personal history factors (Himes,

2.1 | Participants and recruitment

Root, Gammon, & Luthy, 2016). Counselees often have difficulty

As part of a larger study (Kinney et al., 2014, 2016), breast cancer

understanding the implications of indeterminate test results for

survivors were identified through the Utah Population Database

themselves and their relatives (Cypowyj et al., 2009) and may view

and recruited through the Utah Cancer Registry. All survivors met

these as true negative results. Knowing that misunderstanding

the National Comprehensive Cancer Network (NCCN) criteria

and miscommunication of genetic information is common within

(National Comprehensive Cancer Network, 2018) and received

families, a method used by genetic counselors to help counselees

testing for BRCA1/2 mutations. Genetic counseling was provided

share accurate information is a summary letter of test results and

via standardized in‐person or telephone genetic testing and coun-

implications (Roggenbuck et al., 2015).

seling. Post‐test counseling was provided along with standardized

Summary letters are commonly used in genetic counseling practice, and they recount discussions from genetic counseling sessions

summary letters alerting to the possibility that close relatives may
be at increased risk of breast cancer.

and include any genetic test results. Genetic counselors typically

Summary letters provided to survivor counselees included test

write a section in the letter pertaining to counselees' family mem-

results and a brief review of the post‐test genetic counseling session.

bers, including (a) impact of genetic conditions; (b) implications of

All summary letters included a section about family members. While

test results; (c) how to acquire individual genetic testing; and (d)

counselees were encouraged to share information with their family

counseling if needed, and appropriate screening/prevention mea-

members, they were not specifically instructed to give the summary

sures. Summary letters are intended to be used by counselees

letters to family members. Example wording of a summary letter

as an aid to share genetic test results with family and assist with

family section is as follows,
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As we mentioned earlier, your female relatives are

were aware of a summary letter generated through the counseling ses-

still considered at increased risk for developing breast

sion. Interviews were audio‐taped and transcribed.

cancer. We recommend that they have annual clinical breast exams starting by age 25 and begin having
annual mammograms at age [10 years prior to diagnosis OR 35, whichever comes first]. American Cancer
Society currently recommends MRI be added to the

2.3 | Measures
2.3.1 | Amount of information shared

screening plan for women with a 20% or greater life-

To assess the reported amount of information shared by counselees,

time risk for breast cancer. Your relatives may not

participants were asked to rate on a scale of 0–5 how much informa-

meet this criteria based on your history alone, but this

tion was shared with them by their sister or mother about her ge-

additional screening may be appropriate if they have

netic counseling and testing. Researchers told participants that zero

other risk factors or dense breast tissue. However,

should indicate no information was shared and five should indicate

your personal and family history still indicates that

“a great deal” of information was shared.

your [family member] may be at a moderately increased risk for breast cancer. We encourage her to
discuss your results with her physicians and consider
options for increased screening and risk reduction.

2.3.2 | Family history and calculated risk
Participants were mailed a family history data collection form prior
to the telephone interview. They were instructed to collect their

Additionally, all received an educational brochure with information

family history and return the form via mail. During the telephone in-

about BRCA1/2‐related cancer risks, genetic testing, hereditary and fa-

terview, researchers reviewed the family history and asked clarifying

milial risk, and recommended medical management (e.g., screening guide-

questions if needed. Following the telephone interview, research-

lines). All survivor genetic testing results were indeterminate negative.

ers calculated lifetime risk for breast cancer using the Claus model

Each survivor (counselee) referred at least one sister and/or

(Claus, Risch, & Thompson, 1994) on CancerGene software; 5‐year

daughter (participant) who had not previously been diagnosed with

risk levels were calculated using the Breast Cancer Risk Assessment

breast cancer. Daughters or sisters who agreed to participate met

Tool or Gail model (Gail et al., 1989).

the following inclusion criteria: women 40–74 years of age, fluent in
English, having a mother or sister with a personal history of breast
cancer who received BRCA1/2 genetic counseling and testing be-

2.4 | Data analysis

tween 2010 and 2013, and who received an indeterminate nega-

Quantitative data including demographics and amount of informa-

tive BRCA1/2 test result. Participants were excluded if they had a

tion shared about genetic counseling were analyzed using SPSS soft-

personal history of any type of cancer besides nonmelanoma skin

ware version 21 (IBM Corp., Chicago, IL). Analysis included measures

cancer, had ever received genetic counseling or BRCA1/2 testing

of frequencies and percent.

themselves, had a prophylactic mastectomy or oophorectomy, lived

Qualitative data were analyzed as follows. Transcripts were read

outside the United States, and/or were incarcerated. Women of

multiple times to immerse researchers in data and to identify key con-

Ashkenazi Jewish descent were not included because of their ele-

cepts. The research team used descriptive coding as defined by Saldaña

vated risk due to the prevalence of founder mutations in BRCA1/2

(2009) to categorize interview content. Descriptive codes were devel-

(Heramb et al., 2018).

oped and defined by the research team. Initially, each team member
coded five interviews using NVivo version 10 software. The team then

2.2 | Procedures

met to ensure that descriptive codes reflected the entire dataset. In addition, codes were discussed and refined to develop themes and defi-

A mailed questionnaire and a telephone interview were used to

nitions. Once mutually agreed‐upon definitions were developed, each

obtain data from consenting participants (see previously published

interview was coded by two researchers using the refined descriptive

manuscript for full details on study protocol; Himes, Clayton, et al.,

codes and themes. Interrater reliability of major descriptive themes

2016). Data obtained during the telephone interview are the focus of

was measured by Cohen's Kappa, and agreement was 90% or above.

the present manuscript. Further details on measures and the results
of data obtained through the questionnaire are reported elsewhere
(Himes, Clayton, et al., 2016).

3 | R E S U LT S

During the telephone interview, a semi‐structured interview guide
was used. Interviews began with the broad question, “Tell me about

Of 122 family members invited to participate, 100 were eligible and

the experience of having a [sister/mother] go through genetic counsel-

agreed to participate (response rate 82%). Two became ineligible be-

ing.” Probing questions included, “What did she share?”, and “How did

cause they developed breast cancer after agreeing to participate but

she share the information?” Participants were asked specifically about

prior to completing the telephone interview. Ten withdrew from the

their understanding of the counselees’ genetic test results and if they

study after initially agreeing to participate; of those, five contacted

|
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the primary investigator (PI) to withdraw and five were lost to follow‐

TA B L E 1

Sample demographics

up. Those who contacted the PI cited time constraint as the reason

Participants

for withdrawal, particularly as it related to collecting family history
information. Surveys and interviews were completed by 85 partici-

Category

pants; however, four interviews were not recorded. Therefore, study

Age

the final number of participants for the present analysis included 81

Race/ethnicity

women from 63 families, with the range of relative participants per
family being 1–4. Participants from the same family had different responses related to the amount of information they felt was shared
with them and different ways of describing their interpretation of genetic test results. Ages of participants were 40 to 74, of various races/
ethnicities who lived in the United States (see Table 1 demographics).

3.1 | How much information?
Participants were asked to rate on a scale of 0–5 how much information was shared with them by their sister or mother about her
genetic testing and counseling. Most participants rated the amount
as very low, with 42% reporting a 0 or 1 on a 0–5 scale (see Figure 1).

Non‐Hispanic White

Although every participant had a mother or sister who received an
indeterminate negative BRCA1/2 test result, participants were cate-

%

n

80

98.8

1

1.2

High school/GED

11

13.6

Some college/technical
school

30

37.0

College graduate and
beyond

40

49.4

Married or living as
married

65

80.2

Separated or divorced

13

16.0

1

1.2

Asian

M

SD

52

9.0

Education

Marital status

Widowed
Never married

3.2 | Participants understanding of test results

953

Total

2

2.4

81

100.0

Abbreviation: GED: general education diploma (high school
equivalency).

gorized into those who understood the results to be negative, those
who were unaware of test results, those whose understanding was

(n = 9) only found out about test results because of involvement in

consistent with indeterminate negative results, and those who be-

the present study. Women who found out about the test results be-

lieved the test results were positive.

cause of this study were categorized as being unaware of test results, because they would not have become aware had they not been

3.2.1 | Participants who understand test results to
be negative
The majority of participants (52/81) reported hearing their sister or
mother describe their test results as only “negative.” However, par-

included in this study (see participant 12829 in Table 2).

3.2.3 | Perception consistent with
indeterminate negative

ticipants used different words when describing the meaning of “neg-

While no family members described test results using terms “inde-

ative” and did not capture the inference of indeterminate negative.

terminate”, or the synonyms “inconclusive” or “uninformative”, seven

Eighteen of the 52 family members in this group described neg-

participants (7/81) interpreted the meaning of the test result consist-

ative test results in terms of the specific genes tested. For example,

ent with an indeterminate negative finding. We categorized women's

“she probably just said … ‘I don't have the gene,’ (S 12870)” and, “all

responses as consistent with indeterminate negative if the descrip-

she told me is that she tested negative for BRCA 1 and 2,” (D 12890).

tions of test results allowed for the possibility that a genetic cause

Indeed, 34 of the 52 family members who reported being told

could still underlie the pattern of cancer in the family. One partici-

the test result was “negative” specified that to them “negative”

pant in this category attended genetic counseling with her family

meant there was no genetic component to the cancer. For example,

member and was able to accurately describe the meaning of an

one participant with a high lifetime risk of 22.7% reported, “they told

indeterminate result. Six of the seven women mentioned reported

her whatever kind she has, is not the genetic, it's not the inherited

hearing the result was “negative”, but they described a personal in-

[type]” (HR S 12899).

terpretation of the test result in direct contrast to what they were
told (see participant 12937 in Table 2). For example, one participant

3.2.2 | Unaware of test results

referred to the summary letter during the interview process and recognized the initial impression of a negative result was not accurate.

Many family members (22/81) were unaware of any aspect of the

Another participant with a lifetime risk of breast cancer of 26.3% re-

testing and/or test results or forgot if they were told. Some noted

ported that when her mother told her about the genetic test results,

they may have been told but forgot (n = 5), while others were certain

she simply stated, “it came back negative.” However, when asked to

they had never been told (n = 7). Interestingly, some family members

describe the meaning of the test result, she stated,

954
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F I G U R E 1 Participant responses to
interview question, “Please rate on a scale
of zero to five how much information your
[sister/mother] shared with you about
what she learned in her genetic counseling
session—with zero being she shared
nothing about the session to five being
she shared a great deal”

I don't know a whole lot about the B‐R‐C‐A … it sur-

in multiple ways. For example, a counselee may have given initial

prised me, you know, I thought that [BRCA] was the

information via text message followed by face‐to‐face discussions.

breast cancer gene. Obviously it's not, since … both my
mom and my sister had breast cancer and if my mom is
negative [but still got breast cancer], there's obviously
lots of different types, so I don't know  (HR D 12937)

3.3.2 | Directly shared from genetic counselor
Two participants received direct information from the genetic counselor by attending genetic counseling with their sister or mother, there-

Another woman described what she thought after her sister said
the genetic test results were negative:

fore removing secondhand genetic test result information. Of the two,
one described test results consistent with a definition of indeterminate negative; “Since you're related, [and with a history] there's always

Well, it just means that … other factors that contrib-

an increased risk” (S 12947). The second described the meaning of the

uted to her breast cancer, I need to be more careful

test results as only negative, saying “I'm not … going to be a person to

with … Because when she got her results, I mean

get cancer because of my family genetics” (D 12877).

there's a reason why she got breast cancer, and if that
reason is for her, then it could be for me because we
are blood relatives because, I don't know  (S 12840)

3.4 | Summary letter
Each counselee received a summary letter from their genetic counseling session. Counselees were not instructed to share the letter

3.2.4 | Participants who understood test results to
be positive

specifically with their family members, but were instructed to share
information with family members (our participants). Each participant
was asked specifically if they had knowledge or awareness of a sum-

One participant described genetic test results as being “positive”.

mary letter. Twelve of 81 participants (15%) were aware that a let-

She stated that many genes were tested and her sister was “positive

ter existed, either because they received a copy (n = 2), saw a copy

for one” (see participant HR S 12749 in Table 2). It is possible that

(n = 2) or because they were told that there was a letter. Conversely,

this sister had other genetic testing outside of this particular study.

69 of 81 family members (85%) were not aware that counselees had
been provided a summary letter containing information applicable to

3.3 | Method of communication
3.3.1 | Indirectly shared through counselee

both the counselee and the extended family.
Two individuals shared the following:
She didn't talk directly about [the summary letter].

Participants were asked how genetic testing information was

Somehow she got her results. I don't know if they

shared with them. A variety of methods referenced for commu-

called, or they showed her the letter, I just didn't see

nicating information shared in genetic counseling were reported,

it? 

(S 12838)

including face‐to‐face conversations, telephone, text, email, social
media, and family group discussions (see Table 2 fourth column).

So now … I want to … contact her and ask her for that

At times, it was difficult to pinpoint exact methods of communi-

information. Or if they could reprint [the summary

cation. Some reported receiving information multiple times and

letter]. And if she could … copy it to me 

(D 12885)

|
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TA B L E 2

955

Selected comments of women with a sister or mother who attended genetic counseling
Participants' descriptions of
how information was shared by
counselee

Participants' perceptions of test
result as shared by family member

Participants' personal interpretation of test result

51‐Year‐old sister of counselee
(HR S 12923)
Lifetime risk 25.2
5‐Year risk 3.8
Family history
Sister breast 30s—died 30s
Sister breast 50s—died 60s
Paternal aunt breast 80s—died 90s
Maternal aunt breast 70s—died 80s
Nephew non‐Hodgkin’s lymphoma
teens—died 20s
Nephew bone 30s—died 40s
Niece cancerous brain tumor 20s—died
40s
Reported amount information shared 3/5
No summary letter shared

Negative not genetic
Oh, do you know what and, sorry
[crying?] … um, do you know what,
it was very traumatic when she was
first diagnosed, just because our
previous sister had had cancer and,
and had passed away. But … after
the initial stuff, and she had her
genetic tests, and then she was very
relieved, we were all very relieved
when it came back negative, that it
wasn’t genetic, and um, yeah, and do
you know what? She’s gone through
the treatment and done beautifully
and, is back to her normal self

Not increased risk
Um, and, I, all I know is that
it’s, that there’s not a, that the
cancers were not genetically,
it’s not in our genetics

Family told together at lunch
Do you know what? She just told
us. We um, at that time we were
getting together for lunch every
week, just as sisters, and she
just told us at lunch that she had
gotten the results of her test
and, do you know what? … She
really didn’t go into lots of details
about what it means, but just
that, it meant that our risk wasn’t
increased for that

54‐Year‐old sister of counselee
(HR S 12899)
Lifetime risk 22.7
5‐Year risk 4.6
Family history
Sister breast 30s/leukemia 30s—died 30s
Sister breast 50s—died 50s
Maternal grandmother gastric 60s—died
60s
Reported amount information shared 2/5
No summary letter shared

Negative—not genetic
…my first sister was diagnosed and
then my second sister was diagnosed
and she’s younger than me and then
I got really worried, but she went
right to genetic counseling and they
told her whatever kind she has is not
the genetic, it’s not inherited, or I’m
not sure what the … yeah

Not increased risk
So it’s not really making me at
any more risk, I feel

Phone call
And so then she just called me as
soon as she was through and said,
“It’s not. You don’t need to worry
about this,” you know. So she put
my mind at ease

45‐Year‐old sister of counselee (S 12809)
Lifetime risk 11.1
5‐Year risk 11.6
Family history
Sister breast 40s—died 60s
Mother ovarian 40s—died 80s
Paternal aunt lung 70s—died 70s
Maternal cousin breast 30s—died 30s
Maternal cousin breast 50s—died 60s
Maternal cousin breast 30s—died 30s
Reported amount information shared 1/5
No summary letter shared

Negative
And, um, and she said yes and that it
came back negative

Decreased risk
WHAT’S YOUR
UNDERSTANDING OF
WHAT THAT MEANS FOR
YOU AND YOUR RISK?
Um, I, I guess, I would think
that my risk is somewhat
lower

Prompted to ask because of
study—asked through Facebook
YOU MENTIONED EARLIER THAT
SHE DIDN’T SHARE A LOT WITH
YOU UNTIL YOU ASKED HER
ABOUT IT. CAN YOU TELL ME
ABOUT THAT?
Um, I didn’t even know that she’d
had it, um, until basically this
research study came and on the
front, it said something to the
effect that I’d been identified as
someone who—how did it word
it?—um, related to someone who’d
had genetic counseling. And so
when, uh, I was trying to remember my, my sister’s youngest
daughter’s age, I just messaged
her on Facebook and asked her,
um, you know, her age and also
asked her if she had had genetic
counseling because I didn’t know.
She’d never mentioned it before

Participant

(Continues)
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(Continued)
Participants' descriptions of
how information was shared by
counselee

Participants' perceptions of test
result as shared by family member

Participants' personal interpretation of test result

42‐Year‐old daughter of counselee
(D 12890)
Lifetime risk 11.6
5‐Year risk 1.9
Family history
Mother breast 40s, 60s—died 60s
Maternal grandma breast 50s—died 90s
Maternal grandfather prostate 70s—died
90s
Paternal grandma breast 40s—died 90s
Father liver 60s—died 60’s
Maternal cousin thyroid 40’s—died 40’s
Reported amount information shared 4/5
No summary letter shared

Negative—for specific gene
I know, yeah, I know very little about
it. All she told me is that she tested
negative for BRCA 1 and 2

Feels literal interpretation
is no increased risk, but
emotional interpretation is an
increased risk
Um, while there’s a lot I don’t
understand, I suppose it would
mean that … I mean on one
hand I take it as I don’t have a
higher risk than any other average person…
But I just have a hard time
believe that with both my
grandmothers and my mom
having had breast cancer, so. In
my mind, I feel like I’m very high
risk, even without that test…
Even though my mother is
negative, there still seems to be
a family trait of it…
So I don’t feel like her testing
negative, um, that does, that
just doesn’t, that makes me feel
a little safer, but not a lot safer.
(laughs)…

Verbal sharing
…she told me

43‐Year‐old daughter of counselee (HR
D 12829)
Lifetime risk 28.7
5‐Year risk 1.4
Family history
Mother breast 40s—died 60s
Maternal aunt breast 40s—died 60s
Maternal aunt breast 40s and 50s—died
60s
Reported amount information shared 0/5
No summary letter shared

Results not known—no recollection
of test results shared
She did‐ she really didn’t share anything with me…
Yeah, I think I just had forgotten and
I, uh, I didn’t, you know what, that’s
amazing. I, I’ve gotta ask my mother
what, what she learned in that. I,
she may have shared it with me and
I may have just forgotten … Or she
may not have shared it, I just can’t, I
can’t believe I can’t remember that.
I should, I should remember that but
I just don’t

Did not recall test result

Informed name was added to potential participant list for study.
OK? SO HOW’D YOU EVEN
BECOME AWARE THAT SHE
HAD HAD, UM, GENETIC
COUNSELING?
She told me she had and then she
said that she, um, had written
my name down as someone who
would be interested in participating in a test and I said yes, absolutely, I would do that…
So that’s, and, but that is all my
mom told me

64‐Year‐old sister of counselee
(S 12936)
Lifetime risk 9.3
5‐Year risk 7
Family history
Sister breast 30s—died 50s
Mother breast 70s—died 80s
Maternal aunt ovarian 30s—died 30s
Maternal aunt cervical 40s—died 40s
Paternal grandma cervical 40s, gastric
40s—died 40s
Reported amount information shared 5/5
Summary letter shared

Negative
She did not have the mutation. And
that’s what I’m finding out again as I
look at this [the summary letter]

Interpretation is consistent
with definition indeterminate
test result
…And I, I knew when I got it
[the summary letter] from her,
that, you know, I read it, and
I wasn’t that concerned after
seeing it, although I know that
this is not the only thing that
shows whether you kind of
have a risk for breast cancer.
…Well, I think, I think it was a
small relief, but in reading the
materials that went with it …
It did also say that that’s only
one part. That there’s still,
um, a, somewhat of a heredity
factor … or … risk…
M‐HM
Because family members do
have cancer, and there’s just
that susceptibility there …
The way I understood it

Family gathering
We, we do sort of have a Family
reunion maybe once a year? … But
I can’t remember this particular
subject coming up that often.
Except I think she did pass these,
uh, things [summary letters] out at
one of those, uh, times when we
were all together … But, but discussing it, probably didn’t happen
for more than 10 or 15 minutes…
And, um, and since it did come
back that, uh, it, there was no
mutation…
I think, probably, there wasn’t,
you know, that kind of, in the
discussion that there wasn’t that
much to talk about

Participant

(Continues)
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(Continued)

Participant
44‐Year‐old sister of counselee (HR S
12749)
Lifetime risk 33.6
5‐Year risk 2.7
Family history
Sister breast 30s—died 40s
Mother breast 40s—died 60s
Reported amount information shared 4/5
No summary letter shared

Participants' perceptions of test
result as shared by family member

Participants' personal interpretation of test result

Positive
Oh, there were multiple genes I
thought they were testing for and
it seems like we were part, she was
positive for one

Increases risk for family
I just know it puts us in a higher
risk factor and definitely her
daughter…

Participants' descriptions of
how information was shared by
counselee
Family discussion
Oh, we just get together as sisters
every once in a while
M‐HM?
Just talk, and so that’s how she just
educated us, told us, followed up
on it, and told us

Note: Statements in all caps were spoken by the interviewers.

While many had no knowledge about a letter, others (n = 12)

4 | D I S CU S S I O N

were aware of the summary letter. Indeed, one participant, who received a copy of the letter, referred to it during the telephone inter-

This is among the first studies to evaluate family members' under-

view and discovered she had not fully understood the test results

standing of indeterminate negative genetic test results. Other studies

on her first reading.

have evaluated counselees understanding of indeterminate negative
test results (Baars, Ausems, van Riel, Kars, & Bleiker, 2016; Cypowyj

She did send me a copy of it, and also a copy of

et al., 2009; Dorval et al., 2005; van Dijk, 2005). Findings related to

the … pedigree. I see that here as well. And she did

counselees understanding are mixed. Studies by van Dijk (2005) and

send me the results of that. It does say no muta-

Dorval et al. (2005) reported only a small minority of counselees took

tion detected. So … I think when I saw that, I just

the indeterminate negative status as an indication of a negative test

kind of put it in the drawer and didn’t think much

result. In contrast, Cypowyj et al. (2009) found that of 30 counselees

more about it. I think it was very good for her to

with indeterminate BRCA1/2 tests, 14 (47%) were uncertain about the

give us this report … It gives us some good infor-

meaning of the test, nine (30%) believed the results were negative,

mation, and there is somewhat of a relief to know

and seven (23%) believed the results were positive. The lack of clarity

that there is no mutation detected. I think it's good

about the meaning of genetic test results and genomic literacy levels

that it tells you that that doesn't mean that you're

for counselees may be barriers to sharing accurate genetic test infor-

free and clear and don't have to worry about any-

mation, either because the information is perceived to be of little or no

thing. Because, with the history there, I think it's

use to family members or because the information is not well enough

good that they do describe that … you still need to

understood to convey clearly (Cypowyj et al., 2009). Indeed, indeter-

watch things, and do your due diligence for your

minate negative test result interpretation can be difficult to under-

own health. So, I think that was a good communica-

stand, even for counselees who received the information first hand.

tion to have 

(S 12936)

In the present study, many participants were unaware their sister or mother had attended genetic counseling at all, reporting that

Despite the fact that summary letters were provided to all coun-

no or very little information was shared with them about genetic

selees to assist with communication, very few participants reported

counseling. This finding was surprising because counselees provided

knowledge of a letter. Having genetic test results and follow‐up rec-

contact information for their family members, knowing their family

ommendations in writing, whether a summary letter, an email, or text,

members would be contacted for a study related to family communi-

provides a stable source of information for family members to go back

cation about genetic counseling and test results.

and review when needed. Indeed, several participants verbalized a

Many who were aware their sisters and mothers attended coun-

wish for a copy of the summary letter, expressing a desire to read the

seling were completely unaware of test results. Our finding of lim-

information available.

ited family communication about indeterminate negative BRCA test
results is similar to findings in studies of BRCA‐positive families.

[If my sister had been told to send us] a copy of the

Indeed, even when genetic counselors undertake interventions to

letter … that might have been very helpful to have in

help counselees notify family members, a large portion of poten-

my records [rather than to] just say, “Oh, you guys are

tially BRCA‐positive family members remain uninformed (Mendes,

good. You don't have the gene.” … I don’t know how

Paneque, Sousa, Clarke, & Sequeiros, 2016; Sermijn et al., 2016;

much counseling goes on at that point, because …

Suthers, Armstrong, McCormack, & Trott, 2006).

when they do the genetic testing, obviously it’s about
them, but it’s not just about them 

(S 12874)

Prior research offers possible explanations for lack of family disclosure. Genetic test results may not be shared because the cancer
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experience is at the forefront of family focus and diminishes capacity

risk perceptions. Unfortunately, few participants (n = 16) reported

to focus on anything else (Peters et al., 2011). Alternatively, family

high levels of information shared with them. Thus, most participants

members may prefer to share only good news (Peters et al., 2011).

reported lower levels of information shared and had lower levels of

Generous and Keeley (2017) suggested another reason for avoid-

accuracy (standardized path coefficient = 0.33 where perfect accu-

ing topics of family conversation is emotional protection. Emotional

racy would be 1.00; sHimes, Clayton, et al., 2016). Similarly, in the

protection involves evading topics that may cause worry or result

present analysis, we found a lack of understanding of the meaning of

in negative consequences. Another possible explanation for lack of

BRCA1/2 test results on the part of most participants.

sharing indeterminate negative results is results can be difficult to
understand and explain; therefore, the information is truncated to
“negative” (Cypowyj et al., 2009). In the present study, limited in-

4.1 | Study limitations and strengths

formation sharing within families appears to have impacted under-

This study is limited as only participants' perceptions of test results

standing of genetic test results.

were evaluated. It is possible that counselees had a clearer under-

We were unable to report whether including family members

standing of the meaning of “indeterminate negative” than their fam-

in genetic counseling enhanced their understanding of test results.

ily members. Because interviews were conducted with relatives of

Only two participants attended genetic counseling with counselees.

counselees, it is unclear whether misinterpretation was due to mis-

One participant understood the indeterminate negative test result

understanding by women being counseled, or because of the way

and was able to describe that result clearly. The other participant

the information was received by participants. Additionally, only in-

who attended counseling incorrectly described genetic test results

cluding women age 40 and above is a limitation. Involving women as

as not having any genetic connection. With such a small number

young as age 30 would have been more impactful clinically because

of participants attending genetic counseling, drawing a conclusion

screening guidelines differ based on risk level beginning at age 30.

about the effectiveness of firsthand information is not possible.

Finally, there are several risk‐calculating models that take significant

Participants were asked what mode of communication was used

family history into account including Claus, BRCAPRO, BODACIA,

to convey genetic test results. Participants received information

and Tyrer Cuzick. The team relied on the Claus model to calculate

through many methods including face‐to‐face visits, telephone calls,

lifetime risks for participants in this study because that model was

texts, and emails. Two participants received a copy of the genetic

used most commonly at the counseling center where the research

counseling summary letter and two saw it but did not receive a copy.

took place at the time. Risk‐calculating models provide different re-

Often participants reported a variety of methods of communica-

sults and the finding that 10% of the sample had greater than 20%

tion; for example, counselees may have sent a text and also talked

lifetime risk for breast cancer may have been slightly different if an-

about results at a later time. No particular method of family commu-

other model had been used.

nication was connected to stronger understanding of genetic test

This study's strengths include being among the first to evaluate

results. However, participants with written communications from

family members' understanding of indeterminate negative test results

counselees were able to look back at those resources to refresh their

and awareness of summary letters. Additionally, because all coun-

memories. Indeed, several participants mentioned looking back at an

seling and testing was conducted as part of a study protocol, one

email or a letter while gathering family history information for this

can be certain that (a) counselees did receive indeterminate negative

study. One participant discovered that her recollection was incor-

test results and (b) all received a summary letter with instructions

rect. While on the phone with researchers, she pulled her copy of

to share information about genetic counseling and test results with

the genetic counseling summary letter out of a drawer and devel-

family members; although counselees were not instructed to share

oped further clarity about the meaning of her sister's test results

the letter specifically with family members.

(see quote from participant S 12936 in Section 93). Over time, writ-

Screening recommendations for breast cancer vary based on risk

ten forms of communication such as email, blog posts, or summary

level. In a separate analysis published elsewhere, Himes, Clayton,

letters may be a source of reference to look back on for clarity when

et al. (2016) found 10% of participants in this study had risk lev-

questions arise or when family members are ready to accept and

els qualifying them for annual breast MRI screenings in addition to

assimilate the information.

mammography. However, none of the participants at elevated risk

It is interesting to note that in our prior analysis of this sample

had been offered, or received, screening MRI by their primary care

(Himes, Clayton, et al., 2016), we found that participants who rated

providers. These findings demonstrate the importance of communi-

the amount of information shared about genetic counseling as high

cating genetic information to family members.

(4 or 5 on 0–5 scale) had greater accuracy of risk perception. The in-

It is important to emphasize that counselees received only

creased accuracy of risk perception held true regardless of partici-

BRCA1/2 mutation testing, not multigene panel testing. Multigene

pants' cancer‐related distress, numeracy skills, knowledge of breast

panel testing became available in 2013. It is estimated that 2.9%–

cancer genetics, or actual risk of breast cancer as calculated by multi-

11.4% of women who receive multigene panel testing following in-

ple risk assessment models (Himes, Clayton, et al., 2016). This implies

determinate negative BRCA1/2 test results are found to have genetic

that participants who felt they received more information about their

mutations associated with either familial or hereditary risk (Chadwell

family member's genetic counseling session also held more accurate

et al., 2018). The overwhelming belief by our participants, that the
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genetic test results indicated a lack of any genetic component, is of
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concern to the research team, because this belief might deter participants or other family members from receiving multigene panel test-

Indeterminate negative test results are often difficult to explain and

ing. Thus, mutations may go undiagnosed due to lack of information.

challenging to understand. This study demonstrated that family members of breast cancer survivors often do not receive much information

4.2 | Research implications

about what was discussed in genetic counseling sessions and often do
not understand indeterminate negative results. Genetic counselors as

Identifying and informing at‐risk family members will require collab-

well as oncology and primary care providers alike must work together

oration among genetic specialists and primary care providers. Future

to identify ways to better inform relatives about genetic test results

research should evaluate the most effective ways to communicate

and help them understand implications for their own risk.

risk, to both family members and their care providers. This study
adds to a body of evidence demonstrating that filtered information
is rarely effective. Therefore, clear verbal and written information is
needed for family members.
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